De-escalation of breast radiotherapy after conserving surgery in low-risk early breast cancer patients.
Pierfrancesco FrancoGiuseppe Carlo IorioSara BartonciniMario AiroldiCorrado De SanctisIsabella CastellanoUmberto RicardiPublished in: Medical oncology (Northwood, London, England) (2018)
The reduction in the burden related to treatment is becoming more and more important in modern oncology. Radiation therapy is a mainstay option in the postoperative setting for early breast cancer patients after breast-conserving surgery. Nowadays, different options are available to de-escalate radiotherapy in this scenario such as the use of hypofractionated whole-breast radiation, the selective delivery of the boost dose to the lumpectomy cavity, the introduction of accelerated partial breast irradiation and the omission of treatment in appropriately selected patients with low-risk features. We herein provide a review article on this topic.
Keyphrases
- radiation therapy
- early breast cancer
- radiation induced
- minimally invasive
- early stage
- locally advanced
- end stage renal disease
- coronary artery bypass
- neoadjuvant chemotherapy
- ejection fraction
- chronic kidney disease
- palliative care
- small cell lung cancer
- newly diagnosed
- patients undergoing
- squamous cell carcinoma
- prognostic factors
- clinical trial
- percutaneous coronary intervention
- atrial fibrillation
- coronary artery disease
- lymph node
- rectal cancer
- patient reported